Manufacturing Chemist Stand Side with Quotient Sciences

Published: 27-Nov-2024 Featured companies: Quotient Sciences
Manufacturing

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!

Sponsored by Quotient Sciences

In this interview, Manufacturing Chemist Stand Side speaks with Quotient Sciences at CPHI Milan 2024.

For more interviews with leading companies from across the manufacturing pharmaceuticals industry, visit our YouTube channel and hit subscribe.

 

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

Featured companies

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug...
See more

You may also like

Manufacturing

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

Read more
The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers

Trending Articles

  1. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development
  4. Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
  5. CDMO Adragos Pharma acquires aseptic fill-finish manufacturing expert, Baccinex Baccinex has significant knowledge in sterile fill-finish processes for both lyophilised and liquid vials

Relevant companies

See more

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers
Manufacturing

Post-CPHI roundup: novel trends and tech in the CDMO space

Annabel Kartal-Allen (AKA) spoke to Thierry Van Nieuwenhove (TVN), CEO of Quotient Sciences, to discuss the impact of next-generation oral dosage therapeutics, AI technologies and the company’s drug development platform on the pharmaceutical industry
Manufacturing

EnergiVault trial delivers peak performance

Full-scale testing of the EnergiVault cold thermal energy storage system from Organic Heat Exchangers (O-Hx) has seen performance exceed expectations in areas including peak load support, resilience and reliability
Manufacturing

Getting personal: a patient-centred approach to rare disease drug development

In this article, Nazim Kanji, Executive Director, Pediatric Services at Quotient Sciences, explores the challenges associated with developing formulations to treat rare disease indications in diverse patient populations
Manufacturing

Quotient: Accelerating your oncology clinical trials with translational pharmaceutics at CPHI

Located at stand 3H39, Quotient are set to provide clients with an opportunity to accelerate their oncology clinical trials with translational pharmaceutics
Manufacturing

Overcoming bio/pharmaceutical production hurdles: an industry insider perspective

From F-gas regulation to finance and from biologics to personalised medicines, the global drug production environment faces a number of challenges that could potentially stifle innovation and profitability. Dr Kevin Robinson (KSR) recently spoke to key players in the supplier and outsourcing community to better understand what services and solutions are available to keep the pipeline flowing
Manufacturing

Quotient Sciences announces manufacturing and clinical testing partnership

Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain
Subscribe now